| Literature DB >> 31105436 |
Calixte Ida Penda1,2, Francis A Ndongo3,4, Anne-Cécile Z-K Bissek3,5, Mathurin C Téjiokem6, Casimir Sofeu6,7, Else C Moukoko Eboumbou6,8, Sandrine Mindjouli2, Sophie Desmonde7, Louis R Njock2,9.
Abstract
BACKGROUND: To accelerate access to pediatric HIV care in Cameroon, operational challenges in implementing HIV pediatric care need to be identified. The aim of this study was to assess the knowledge, attitudes, and practices of health care workers regarding pediatric HIV infection in Cameroon.Entities:
Keywords: HIV; HIV-infected children; antiretroviral therapy; pediatric care
Year: 2019 PMID: 31105436 PMCID: PMC6501467 DOI: 10.1177/1179556519846110
Source DB: PubMed Journal: Clin Med Insights Pediatr ISSN: 1179-5565
Sociodemographic and occupational characteristics of health care providers in charge of HIV pediatric care (Cameroon, 2014), N = 103.
| Variable | n (%) or median (IQR) |
|---|---|
| Age (years) | 39.0 (32.0-48.0) |
| Female | 85 (73.9) |
| Education level | |
| Primary | 2 (1.7) |
| Secondary | 53 (46.1) |
| Tertiary | 60 (52.2) |
| Seniority at the current post (years) | 4.4 (2.0-8.0) |
| Initial training level | |
| Nurse’s aide | 11 (9.6) |
| Social worker | 6 (5.2) |
| Pharmacy assistant | 6 (5.2) |
| Psychosocial agent | 22 (19.1) |
| Nurse | 33 (28.7) |
| Engineer statistician | 2 (1.7) |
| General practitioner | 19 (16.5) |
| Pediatrician | 4 (3.5) |
| Pharmacist | 0 (0.0) |
| Psychologist | 2 (1.7) |
| Assistant laboratory technician | 10 (8.7) |
| Previous capacity building in HIV pediatric care | 64 (62.1) |
Abbreviations: n, size in the variable category; IQR, interquartile range.
Knowledge, attitudes, and practices of health care providers in charge of HIV pediatric care (Cameroon, 2014).
| Knowledge, attitude, and practice assessed | Level of knowledge, attitude, and practice of health care provider | ||
|---|---|---|---|
| Health workers (N = 59) | Community agents (N = 44) | All health care providers (N = 103) | |
| Modes of HIV transmission | |||
| Mother to child[ | 57 (96.6) | 44 (100.0) | 101 (98.1) |
| Sexual abuse[ | 26 (44.1) | 9 (20.5) | 35 (34.0) |
| Use of common sharp objects with HIV-infected person | 1 (1.7) | 1 (2.3) | 2 (1.9) |
| Preventive treatment of infants born to HIV+ mothers on ART | |||
| Nevirapine during breastfeeding period | 25 (42.4) | 26 (59.1) | 51 (49.5) |
| Nevirapine for 6 weeks[ | 28 (47.5) | 15 (34.1) | 43 (41.7) |
| Do not know | 5 (8.5) | 3 (6.8) | 8 (7.8) |
| Suspicion of HIV-infected children | |||
| Positive PCR[ | 57 (96.6) | 42 (95.5) | 99 (96.1) |
| HIV+ mother[ | 3 (5.1) | 1 (2.3) | 4 (3.9) |
| Malnutrition[ | 3 (5.1) | 1 (2.3) | 4 (3.9) |
| History of cough for 3 weeks[ | 2 (3.,4) | 0 (0.0) | 2 (1.9) |
| HIV+ father | 0 (0.0) | 1 (2.3) | 1 (1.0) |
| Children with no suggestive sign | 0 (0.0) | 2 (4.5) | 2 (1.9) |
| Knowledge on HIV mother-to-child transmission risks in children born to HIV+ mothers | |||
| 100% of children in the absence of ART in the mother | 9 (15.3) | 0 (0.0) | 0 (0.0) |
| 30% of children in the absence of ART in the mother[ | 17 (28.8) | 0 (0.0) | 0 (0.0) |
| 5% of children if the mother on ART[ | 27 (45.8) | 0 (0.0) | 0 (0.0) |
| Administration of co-trimoxazole in HIV-exposed infant | |||
| Independent of age[ | 37 (62.7) | NA | NA |
| Independent of CD4 count | 13 (22.0) | NA | NA |
| Independent of the viral load | 6 (10.2) | NA | NA |
| Children below the age of 5 years | 6 (10.2) | NA | NA |
| Indications of ART initiation in HIV+ child | |||
| Below the age of 2 years[ | 3 (5.1) | NA | NA |
| HIV+ children with tuberculosis[ | 13 (22.0) | NA | NA |
| Positive PCR[ | 47 (79.7) | NA | NA |
| Positive HIV serology[ | 21 (35.6) | NA | NA |
| First-line ART regimen in HIV+ child in case of PMTCT failure | |||
| ABC + 3TC + EFV | 15 (25.4) | NA | NA |
| ABC + DDI + LPV/r | 4 (6.8) | NA | NA |
| AZT + 3TC + NVP | 22 (37.3) | NA | NA |
| 3TC + TDF + EFV | 14 (23.7) | NA | NA |
| AZT + 3TC + LVP/r[ | 18 (30.5) | NA | NA |
| ABC + 3TC + LVP/r[ | 15 (25.4) | NA | NA |
| Do not know | 12 (20) | NA | NA |
| Management of HIV-tuberculosis co-infection | |||
| 2 weeks of antituberculous treatment and then ART initiation[ | 37 (62.7) | NA | NA |
| Antituberculous treatment and ART jointly | 4 (6.8) | NA | NA |
| ART after the end of antituberculous treatment | 9 (15.3) | NA | NA |
| Do not know | 9 (15.3) | NA | NA |
| HIV-exposed new born tracking methods in the labor room | |||
| Health care providers dedicated to HIV+ mothers’ deliveries[ | 24 (40.7) | 9 (20.5) | 33 (32.) |
| Linkage formed between the delivery room and the ATC/TU[ | 23 (39.0) | 21 (47.7) | 44 (42.7) |
| Accompanying the mother from maternity to the ATC/TU[ | 18 (30.5) | 20 (45.5) | 38 (36.9) |
| No specific activity in relation to tracking | 11 (18.6) | 5 (11.4) | 16 (15.5) |
| Do not know | 7 (11.9) | 5 (11.4) | 12 (11.7) |
| Practical situations requiring counseling for HIV screening in the child | |||
| Children of a person living with HIV or HIV+ sibling | 50 (84.7) | 38 (86.4) | 88 (85.4) |
| Children with severe malnutrition[ | 23 (39.0) | 6 (13.6) | 29 (28.2) |
| Children hospitalized for severe pathology[ | 27 (45.8) | 9 (20.5) | 36 (35.0) |
| Children received at external consultations[ | 11 (18.6) | 5 (11.4) | 16 (15.5) |
| Recommended action in case of refusal of HIV screening in the child | |||
| Discussion with the second parent jointly[ | 25 (42.4) | 24 (54.5) | 49 (47.6) |
| Make the parent attend a support group for parent’s HIV+ children[ | 21 (35.6) | 15 (34.1) | 36 (35.0) |
| Refer the parent to another health care provider[ | 24 (40.7) | 17 (38.6) | 41 (39.8) |
| Blood drawn for HIV test in the child without knowing of the parent | 1 (1.7) | 0 (0.0) | 1 (1.0) |
| Specific follow-up consultation of HIV-exposed infants | 42 (71.2) | 37 (84.1) | 79 (76.7) |
| Frequency follow-up consultation of HIV-exposed infants | |||
| Documented monthly appointments[ | 24 (40.7) | 28 (63.6) | 52 (50.5) |
| Appointments adjusted to EPI vaccinal calendar[ | 22 (37.3) | 11 (25.0) | 33 (32.0) |
| Verbal appointment at 6 weeks | 13 (22.0) | 7 (15.9) | 20 (19.4) |
| Health care provider decision to initiate ART in the following context | |||
| Individual decision | 3 (5.1) | NA | NA |
| Adult therapeutic committee | 31 (52.5) | NA | NA |
| Pediatric therapeutic committee[ | 21 (35.6) | NA | NA |
| Therapeutic committee of the nearest ATC/TU[ | 6 (10.2) | NA | NA |
| Do not know | 5 (8.5) | NA | NA |
| Frequency of medical follow-up of HIV+ children on ART | |||
| Children seen in case of disease | 8 (13.6) | NA | NA |
| Monthly[ | 37 (62.7) | NA | NA |
| Quarterly[ | 12 (20.3) | NA | NA |
| Every 6 months | 9 (15.3) | NA | NA |
| Do not know | 2 (3.4) | NA | NA |
| HIV status disclosure activity | 32 (54.2) | 26 (59.1) | 58 (56.3) |
| Age at disclosure | |||
| 8-10 years | 2 (3.4) | 0 (0.0) | 2 (2.0) |
| 11-13 years[ | 19 (32.2) | 14 (31.8) | 33 (32.0) |
| 14-17 years | 11 (18.6) | 12 (27.3) | 23 (22.3) |
| HIV status disclosure issues | |||
| Parents’ reluctance | 40 (67.8) | 29 (65.9) | 69 (67.0) |
| Insufficient health care provider skills | 5 (8.5) | 9 (20.5) | 14 (13.6) |
| Lack of organization of child preparation | 10 (16.9) | 5 (11.4) | 15 (14.6) |
| Other | 7 (11.,9) | 3 (6.8) | 10 (9.7) |
| Therapeutic education activities | 32 (54.2) | 20 (45.5) | 52 (50.5) |
| Use of therapeutic education pedagogic tools | 12 (20.3) | 12 (27.3) | 24 (23.3) |
| Frequency of therapeutic education sessions | |||
| Adhesion consultation before ART initiation and then adherence consultations when necessary | 12 (20.3) | 0 (0.0) | 0 (0.0) |
| Adhesion consultation before ART initiation and then adherence consultations every 6 months[ | 10 (16.9) | 0 (0.0) | 0 (0.0) |
| Adherence consultation in case of CD4 count decrease | 2 (3.4) | 0 (0.0) | 0 (0.0) |
| Interview not formalized with parent | 4 (6.8) | 0 (0.0) | 0 (0.0) |
| Psychological follow-up | 16 (27.1) | 18 (40.9) | 34 (33.0) |
| Psychological follow-up activities | |||
| Therapeutic education by age group[ | 0 (0.0) | 2 (4.5) | 2 (1.9) |
| Counseling[ | 11 (18.6) | 10 (22.7) | 21 (20.4) |
| Psychosocial investigation[ | 0 (0.0) | 1 (2.3) | 1 (1.0) |
| Support group[ | 3 (5.1) | 3 (6.8) | 6 (5.8) |
| Home visit[ | 2 (3.4) | 8 (18.2) | 10 (9.7) |
| Specific ways of implementation of the search for HIV+ mothers to do PCR in their infants in the health care facility | 24 (40.7) | 23 (52.3) | 47 (45.6) |
| Methods of search for HIV+ mothers to do PCR in their infants | |||
| Phone call[ | 7 (11.9) | 10 (22.7) | 17 (16.5) |
| Home visit[ | 7 (11.9) | 1 (2.3) | 8 (7.8) |
| Phone call and home visit[ | 9 (15.3) | 10 (22.7) | 19 (18.4) |
| Specific ways of implementation of return of PCR results to the mothers of HIV-exposed infants | 23 (39) | 12 (27.3) | 35 (34.0) |
| Methods of return of PCR results to the mothers of HIV-exposed infants[ | |||
| Phone call | 11 (18.6) | 8 (18.2) | 19 (18.4) |
| No search undertaken | 11 (18.6) | 2 (4.5) | 13 (12.6) |
| Methods of identification of children lost to follow-up | |||
| Search for missed appointments in the pharmacy register | 35 (59.3) | 20 (45.5) | 55 (53.4) |
| Control of the monthly list HIV+ children waited | 9 (15.3) | 10 (22.7) | 19 (18.4) |
| No method undertaken | 15 (25.4) | 12 (27.3) | 27 (26.2) |
| Method of search for lost to follow-up | |||
| Phone call | 39 (66.1) | 35 (79.5) | 74 (71.8) |
| Home visit | 33 (55.9) | 29 (65.9) | 62 (60.2) |
| Search for address and phone number of the parent of the child | 8 (13.6) | 5 (11.4) | 13 (12.6) |
| No search undertaken | 6 (10.2 | 2 (4.5) | 8 (7.8) |
| Do not know | 3 (5.1) | 0 (0.0) | 3 (2.9) |
Abbreviations: ART, antiretroviral treatment; ATC, approved treatment center; EPI, Expanded Program of Immunization; n, size of the variable in the category; NA, not applicable; PCR, polymerase chain reaction; PMTCT, prevention of mother-to-child transmission of HIV; TU, treatment unit.
Recommended attitudes and practices.